Myricetin suppresses invasion and migration of human lung adenocarcinoma a549 cells: Possible mediation by blocking the erk signaling pathway

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 9, 2009, Pages 3490-3499

  Shih, Yuan Wei ^a   Wu, Pei Fen ^b   Lee, Yi Chieh ^a   Shi, Ming Der ^c   Chiang, Tai An ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c Yongkang Veterans Hospital   (Taiwan)

Author keywords

AP 1; ERK1 2; Invasion; Migration; MMP 2; Myricetin; NF kB; U PA

Indexed keywords

ENZYME INHIBITOR; FLAVONOID; GELATINASE A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYRICETIN; UROKINASE;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CELL ADHESION; CELL MOTION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LUNG TUMOR; PHOSPHORYLATION; TUMOR CELL LINE;

ADENOCARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM INVASIVENESS; PHOSPHORYLATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 66149132324     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf900124r     Document Type: Article

References (30)

1. Cody, V. Crystal and molecular structures of flavonoids. Prog. Clin. Biol. Res. 1998, 280, 29-44.
2. Aherne, S. A.; O'Brien, N. M. Protection by the flavonoids myricetin, quercetin, and rutin against hydrogen peroxideinduced DNA damage in Caco-2 and Hep G2 cells. Nutr. Cancer 1999, 34, 160-166.
3. Yanez, J.; Vicente, V.; Alcaraz, M.; Castillo, J.; Benavente-Garcia, O.; Canteras, M.; Teruel, J. A. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr. Cancer 2004, 49, 191-199.
4. Blonska, M.; Czuba, Z. P.; Krol, W. Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages. Scand. J. Immunol. 2003, 57, 162-166.
5. Lu, J.; Papp, L. V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res. 2006, 66, 4410-4418.
6. Zhang, Q.; Zhao, X. H.; Wang, Z. J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol. 2008, 46, 2042-2053.
7. Nadova, S.; Miadokova, E.; Cipak, L. Flavonoids potentiate the efficacy of cytarabine through modulation of drug-induced apoptosis. Neoplasma 2007, 54, 202-206.
8. De Leo, M.; Braca, A.; Sanogo, R.; Cardile, V.; De Tommasi, N.; Russo, A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells. Planta Med. 2006, 72, 604-610.
9. Lee, K. M.; Kang, N. J.; Han, J. H.; Lee, K. W.; Lee, H. J. Myricetin down-regulates phorbol ester-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking activation of nuclear factor kappa B. J. Agric. Food Chem. 2007, 55, 9678-9684.
10. Ko, C. H.; Shen, S. C.; Lee, T. J.; Chen, Y. C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 2005, 4, 281-290.
11. Greenlee, R. T.; Hill-Harmon, M. B.; Murray, T.; Thun, M. Cancer statistics. CA Cancer J. Clin. 2001, 51, 15-36.
12. Shivapurkar, N.; Reddy, J.; Chaudhary, P. M.; Gazdar, A. F. Apoptosis and lung cancer: a review. J. Cell Biochem. 2003, 88, 885-898.
13. Erridge, S. C.; Moller, H.; Price, A.; Brewster, D. International comparisons of survival from lung cancer: pitfalls and warnings. Nat. Clin. Pract. Oncol. 2007, 4, 570-577.
14. Murrer,D.; Breathnach,R.;Engelman,A.;Millon,R.; Bronner, G.; Flesch, H.;Dumont, P.; Eber, M.;Abecasis, J. Expression of collagenase related metalloproteinases genes in human lung or head and neck tumors. Int. J. Cancer 1991, 48, 550-556.
15. Gontero, P.; Banisadr, S.; Frea, B.; Brausi, M. Metastasis markers in bladder cancer: a review of the literature and clinical considerations. Eur. Urol. 2004, 46, 296-311.
16. Parks, W. C.; Shapiro, S. D. Matrix metalloproteinases in lung biology. Respir. Res. 2001, 2, 10-19.
17. Foda, H. D.; Zucker, S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov. Today 2001, 6, 478-482.
18. Khasigov, P. Z.; Podobed, O. V.; Gracheva, T. S.; Salbiev, K. D.; Grachev, S. V.; Berezov, T. T. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis. Biochemistry (Moscow) 2003, 68, 711-717.
19. Duffy, M. J.; Duggan, C. The urokinase plasminogen activator system: a rich source of tumour markers for the individualized management of patients with cancer. Clin. Biochem. 2004, 37, 541-548.
20. Itoh, Y.; Nagase, H. Matrix metalloproteinases in cancer. Essays Biochem. 2002, 38, 21-36.
21. Westermarck, J.;Kahari, V.M.Regulation ofmatrixmetalloproteinase expression in tumor invasion.FASEBJ. 1999, 13, 781-792.
22. Aguirre Ghiso, J. A.; Alonso, D. F.; Farias, E. F.; Gomez, D. E.; de Kier Joffe, E. B. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem. 1999, 263, 295-304.
23. Chen, P.N.;Hsieh,Y. S.;Chiou,H.L.;Chu, S.C. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem.-Biol. Interact. 2005, 156, 141-150.
24. Robinson, M. J.; Cobb, M. H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 1997, 9, 180-186.
25. Turner, N. A.; Aley, P. K.; Hall, K. T.; Warburton, P.; Galloway, S.; Midgley, L.; O'regan, D. J.; Wood, I. C.; Ball, S. G.; Porter, K. E. Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J. Mol. Cell Cardiol. 2007, 43, 168-176.
26. Peng, P. L.; Hsieh, Y. S.; Wang, C. J.; Hsu, J. L.; Chou, F. P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol. Appl. Pharmacol. 2006, 214, 8-15.
27. Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
28. Shao, Z. M.; Wu, J.; Shen, Z. Z.; Barsky, S. H. Genistein inhibits both constitutive and EGF- stimulated invasion in ERnegative human breast carcinoma cell lines. Anticancer Res. 1998, 18, 1435-1439.
29. Cha, H. J.; Bae, S. K.; Lee, H. Y.; Lee, O. H.; Sato, H.; Seiki, M.; Park, B. C.; Kim, K. W. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res. 1996, 56, 2281-2284.
30. Rothhammer, T.; Hahne, J. C.; Florin, A.; Poser, I.; Soncin, F.; Wernert, N.; Bosserhoff, A. K. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell. Mol. Life Sci. 2004, 61, 118-128.